{
  "id": 16603105,
  "title": "Amgen's cancer drug combo cut death risk by 58% in lung cancer trial",
  "url": "https://urgent.news/2026/10/26/amgens-cancer-drug-combo-cut-death-risk-by-58-in-lung-cancer-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-26T12:40:24.000Z",
  "source": {
    "name": "Quartz",
    "slug": "quartz",
    "url": "https://qz.com/amgen-imdelltra-imfinzi-lung-cancer-death-risk-102626"
  },
  "original_language": "en",
  "account": null,
  "summary": "Median survival reached 21.1 months with Imdelltra plus AstraZeneca's Imfinzi, versus 12.7 months for Imfinzi alone",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Ynetnews Culture",
        "title": "New lung cancer drug adds nearly six months of survival; stomach cancer treatment doubles it",
        "url": "https://urgent.news/2026/10/26/new-lung-cancer-drug-adds-nearly-six-months-of-survival-stomach",
        "published": "2026-10-26T08:20:08.000Z"
      },
      {
        "outlet": "The Hindu - Sci-Tech",
        "title": "Amgen drug combined with immunotherapy extends survival in lung cancer trial",
        "url": "https://urgent.news/2026/10/26/amgen-drug-combined-with-immunotherapy-extends-survival-in-lung",
        "published": "2026-10-26T13:25:53.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}